VCR - Ventracor Limited

[stockmaster]

VCR has been going for the past 10 months, however it seems the downward trend might have stopped.

"We see European market sales commencing in FY07 and US market sales (for the relatively limited bridge-to-transplant indication) starting in FY10. We expect losses to be incurred until FY10, with the company turning its first profit in FY11.
Recommendation -12m: $1.00" By Aegis.

I personally believes the share is facing north for the next couple of months or as least weeks. It seems the graph for the past 2 months is supporting my argument! .

 

[samsterchan]

VCR - look at it today !

VCR looking great again.....
check this good announcement out

http://www.medicalnewstoday.com/medicalnews.php?newsid=46544

At the rate this goes, it will hit $1 in the next few few months.
Wait for the next market sensitive announcements - more hospitals are coming on board ! Technical analysis points to it breaching the $0.93 cents mark - today it already hit that and went as high as 0.935.

This stock is on the way up again !
Support an Aussie manufacturer that is doing a great cause for medical advancement !

 

[Knobby22]

I wish you all luck, I would love to see VCR succeed.

 

[saichuen]

good luck to those who is holding. i've previously hold this stock and decided to exit with a lost so that i can put my money into other stocks that may be returning more at the moment (like commodities? )

i reckon the problem with this stock (in my opinion) is that the people who is interested in it is probably expecting it to be the next cochlear???

my 2cents worth...

cheers!

 

[samsterchan]

VCR - more buyers than sellers

Look at this go - I reckon this is going to end at close to the 93 cents mark.

It's on the way up again right this moment !

 

[samsterchan]

Great video clip on VCR

Take a look at the following attachment

http://staging.fusefarm.com.au/ventracor/news/news_content.asp

View the video clip - bound to get your heart pumping !

More interest than ever before in this stock. The preliminary results to be released in Spain this week will be sure to increase the market awareness and share price of this stock !


VCR - National TV coverage - 06 April 06
Thursday April 6th, 2006

Australian Broadcasting Corporation
Artificial heart trial results promising

VIEW VIDEO CLIP


TV PROGRAM TRANSCRIPT

HOST KERRY O'BRIEN: Two years ago we looked at an Australian invention undergoing trials to help alleviate the critical predicament facing people who need a heart transplant. Worldwide, only about 3,000 heart transplants are performed each year, while it's estimated that between 100,000 and 200,000 people need one. One alternative that's been tested by cardiac specialists at Melbourne's Alfred Hospital is an Australian-invented mechanical heart.

Since the trial began the artificial heart has been implanted in more than 50 patients around the world and the preliminary results to be presented at a conference in Spain this week, show survival rates equivalent to heart transplants.

The artificial heart is particularly useful as a lifeline for patients who are waiting for a transplant or to extend the lives of those who are too old to be eligible for transplant. Natasha Johnson reports.

NATASHA JOHNSON: Wandering around Victoria's National Gallery, 77-year-old Gerry Levine is very much alive, even though his heart effectively stopped working more than two years ago.

MARIE PARKINSON-LEVINE: It's totally unbelievable. He could hardly walk a few steps just before he had the operation and he looked so pallid and so sick and when I look at him now and he's like 2.5 years older, basically, it's unbelievable. He's getting younger. Whereas, we mortals are getting older.

NATASHA JOHNSON: Two years and four months post implant, Gerry Levine is the longest surviving recipient of an Australian invented artificial heart. The Ventr-Assist device is implanted under the abdominal wall under the ribs and hooked up to the failing heart. A drive line protruding through the patient's stomach is connected to a portable battery pack. Unlike the human heart that contracts, the mechanical version has a continuously spinning rotor ensuring a constant flow of blood and patients therefore have no pulse. What's it like not having a pulse?

GERRY LEVINE: (Laughs).

MARIE PARKINSON-LEVINE: Funny sometimes.

GERRY LEVINE: Funny sometimes. I do carry a little identity disk which says I have to be taken back to the Alfred if there's an emergency and an instruction book which is normally carried in the trolley. It does say don't assume that because there's no pulse the patient is dead. (Laughs).

NATASHA JOHNSON: We first met Gerry Levine as he and a handful of other elderly patients agreed to take part in the first human trial of the Ventr-Assist device at the Alfred Hospital in Melbourne.

PROFESSOR DON ESMORE, ALFRED HOSPITAL: He's brave and he's been shown resolve and that's why he's done well.

NATASHA JOHNSON: Surgeon Don Esmore and the Alfred team has pioneered use of the device which costs $100,000. Three years on it's now been implanted into more than 50 critically ill patients worldwide.

PROFESSOR DON ESMORE: This pump is for people who've had the full gamut of treatment for heart failure. They have no other option either surgically or medically. They are functioning probably 10 per cent of normal with both a poor life expectancy and a very poor quality of life.

NATASHA JOHNSON: In such a seriously ill population there have been deaths, but the latest trial results are showing good survival rates.

PROFESSOR DON ESMORE: The survival rate at one year currently for the trial is 82% and the world figure for heart transplantation is around 80%. At one year if your Ventr-Assist is put in, your chance of living a year are the same as a heart transplant and currently we are looking at a 2-year survival which would appear to be around the 60% mark. Heart transplants are maybe a bit better than that, maybe 70 or 75% but we're talking about evolving technology.

NATASHA JOHNSON: The candidates are either over 65s like Gerry Levine who are too old or sick to qualify for a heart transplant or younger patients like 17-year-old Kim Cowcher who are trying to stay alive long enough for a donor heart to become available. In an unlucky run of illness Kim Cowcher suffered non-Hodgkins lymphoma, a paralysing auto-immune disease and then heart failure from her chemotherapy. Last July she fell into a coma and her mother was told her only hope of survival was the artificial heart which was really only designed for adults.

SHARON NICHOLSON: It was very scary, but given the fact there was no other options, we don't have a choice, it is either she turn the machine off or try this. So when you are faced with that, there's no decision to make.

KIM COWCHER: I woke up on my 17th birthday out of my coma and told it was two weeks after my fly back and I'm like, "No, it's the next day." And I'm told "No, Kim it's two weeks later". It was my birthday and they were explaining to me I'm on this machine and you can feel it whirring and I felt all of these things in your stomach and you've got a big machine there and a cord. They said, "We don't know how you'll go on this." I was sitting there thinking, "Am I going to live or die?" They couldn't give you a direct answer.

NATASHA JOHNSON: Kim Cowcher is the youngest Australian to receive the artificial heart and while she requires a carer 24 hours a day and ongoing hospital monitoring, she can enjoy time out with her family and continue her schooling.

KIM COWCHER: I thought it was a gutter ball.

NATASHA JOHNSON: But she and her mum are still getting used to her tethered existence to the power pack and its batteries which need changing every three to four hours.

KIM COWCHER: It is like having a little friend that's stuck to your pocket. Every 2 seconds, every time you get up to go to the toilet get up to get a drink you've got to take your friend with you. It's very stressful at times. I have got up once and forgot it and it came flying back and hit the wall. That was a bit funny but I didn't hurt myself.

SHARON NICHOLSON: I'm scared a lot of times you wake up in the morning and I instantly listen for the alarm or wake up through the might and think is it alarming. It beeps like a truck backing and if I hear that I yell out, "Kimberley!" She says, "It's not me."

MARIE PARKINSON-LEVINE: There's a plug down there. We can plug you in alright. That was easier than I thought.

NATASHA JOHNSON: While they have plenty of backup batteries, Gerry Levine and wife Marie prefer to plug in whenever you can and wherever they can.

MARIE PARKINSON-LEVINE: ...and your reserve is full, so no problems.

NATASHA JOHNSON: As Gerry Levine and Kim Cowcher cherish the days they might not have otherwise seen, a new trial of the Ventr-Assist is being planned with the hope that current survival rates can ultimately be pushed out to five years.

GERRY LEVINE: I'm quite happy it should go on for as long as possible.

KIM COWCHER: Oh, yes! I feel normal. I don't feel there's something wrong with me because I'm with my family and we're all laughing and smiling and having fun, rather than sitting around a hospital bed having that time bomb tick off, wondering is it time, isn't it time?
O’BRIEN: Natasha Johnson with that story of hope for young and old.

 

[Lucky_Country]

VCR next 6 months this one will be a winner after european approval

 

[BraceFace]

VCR next 6 months this one will be a winner after european approval

I'd have to see it to believe it.
This is a high risk punt.

Once bitten, twice shy!

 

[Morgan]

Just be careful with this one.
My Ventracor story:
I bought in many years ago for $1.30 because I believed in the fundamentals after seeing the technology featured on ABCs "Catalyst".
Price rocketed to $3.76 within weeks and I thought I was on to a winner.
However then began the slow downtrend which if you look back on the long term chart you will see.
Sold out in June this year for a loss (to offset capital gains) as I couldn't take the pain any longer. Note how the price only goes up after the end of the financial year then resumes its favourite downtrend.
The reality is that inventions such as this take an excruciatingly long time to get to market due to the many, many regulatory hoops that must be jumped through. Also big cash burn by the company.
In addition there are competitors (eg Heartware), fights over patents, plus the chance that by the time product is approved someone else will be onto a new and better technology.
Yes, the fundamentals are still there, but that doesn't always mean the share price will act accordingly. I hoped for years that this would be the next Cochlear- so once again, be careful if this is what you are expecting.

 

[Lucky_Country]

All stocks have there risk just ask westpoint investors but VCR has its risk but positives outweigh the negatives and Eurpoean approval is almost there with a high implant sucess rate

 

[Knobby22]

Did anyone see the 7:30 Report last night?

It finished with a lovely story. Anyone who follows this stock will probably remember the young adult girl (around 18) who was put on the Ventra - assist device as she got some sort of heart damage caused by a virus to keep her alive. I felt so sorry for her as the device really is a bit archaic in reality and she had to walk around with a battery pack and you know infection could kill her.

Anyway, after a year her heart recovered! They removed the device and she is now healthy. Even if this company goes nowhere at least the investors will know they have made a difference.

Trials are on worldwide but there are so many competitors. It may one day be a winner but I am not inclined to own any at this stage.

K

 

[nioka]

Did anyone see the 7:30 Report last night?

It finished with a lovely story. Anyone who follows this stock will probably remember the young adult girl (around 18) who was put on the Ventra - assist device as she got some sort of heart damage caused by a virus to keep her alive. I felt so sorry for her as the device really is a bit archaic in reality and she had to walk around with a battery pack and you know infection could kill her.

Anyway, after a year her heart recovered! They removed the device and she is now healthy. Even if this company goes nowhere at least the investors will know they have made a difference.

Trials are on worldwide but there are so many competitors. It may one day be a winner but I am not inclined to own any at this stage.

K

I have lost more on this stock than any other. Now I don't feel so bad.I did keep 1000 shares as a momento.

 

[Sultan of Swing]

I have lost more on this stock than any other. Now I don't feel so bad.I did keep 1000 shares as a momento.

That SORTA makes me feel better although I do feel bad for you.

I did a complete round trip. Bought at 35 cents about 6 years ago, sold at 55 cents, rebought at 68 cents, held all the way up to $3.81 and down again, then sold about 3 months ago at 66 cents.

AAUUGGHHHHHHH!!!!

I didn't know about stop-losses then but sure learned quick. I think it's commonly referred to as greed : .

Hmmmm, i could think of all the 'what ifs' all day.

 

[nioka]

I didn't know about stop-losses then but sure learned quick. I think it's commonly referred to as greed :

I don't believe in stop losses. Each day I look at the price and check the stock and decide if it worth holding at it's current price. If it is I hold if not then I sell. Most times it works, that time it did not. I bought my first at 35c more at 72c then more at $2.25 More at $2.70 then bang and I held on too long. Got out at $1.25

 

[petal]

VCR continues a steady rise on high volume finishing at 99.5 cents.

 

[visual]

Actually it finished 1.035.

 

[ducati916]

Total revenue for 2005 was $2.7million composed of "interest" earned on cash balances.

The net loss was a further $27million.
Total earnings of Directors = $1.16million or 4.3% of the total loss.
Total earnings of executives = 1.59million or 5.9% of the loss
This doesn't even include options & performance bonuses.

Revenues;
These fell in 2005.
Why?
Because as the cash is spent, so interest payments fall.

Total accumulated losses.
A staggering $84.7million.
Total funds contributed via shareholders = $123.0million

This company as an "investment" is of the most speculative nature. It has no earnings, burns cash at an unbelievable rate, and has no concrete idea of when if ever, earnings will appear.

As if that was not enough, the quality of the medical research is very low.
Patient numbers, recruited into the trials are so low as to provide zero statistical significance. The patient follow-up is too short.

The actual technology is barbaric.
We are talking about an open wound, that is vulnerable to opportunistic infection. The technology failed, and had to be placed on recall. That no patients died, may be down to sheer luck, but then again we'll never know, as the patient numbers were just so low.

With the increasing advances within stem-cell treatments, this is a real non-starter. CHF is an easily diagnosed, slow progressing condition, and very treatable in early stages. The potential monetization of this product will be fraught with difficulty.

jog on
d998

This is just one of those really horrible stocks that should be avoided like the plague, unless you know absolutely nothing about it, and play it as a pure speculation.

jog on
d998

 

[visual]

This is just one of those really horrible stocks that should be avoided like the plague, unless you know absolutely nothing about it, and play it as a pure speculation.

jog on
d998

Oh Duc,
good to see that everything is still as it should be.LOL.
Keep pushing that barrel,won`t you.
This technology is keeping people alive ,not only that it also has benefits that they didn`t expect ,like repairing the heart muscle,but we`ve been down that road already,keep it up,Duc.

 

[nautilus]

Made a tidy gain of 4% today, just closed it.

Would have been a 7% gain if not of Etrade's blunder.

My contract note wasn't sent to St George Margin Lending and I can't sell at the high today. Send my order to sell at $1.19 but rejected with a message saying I don't currently hold any stock.

Etrade has been giving me headache lately.

 

[LifeisShort]

In the long run you can probably make more cash by getting a stockbroker to immediately place an order for you. Even though it might cost you more for brokerage but there are other benefits...such as research etc.

Thats unless you are only punting with $500 on every trade